NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM1439719 Query DataSets for GSM1439719
Status Public on Apr 22, 2015
Title Tet2-/-_AML1_ETO_p2_Rep1
Sample type RNA
 
Source name Kit-enriched hematopoietic bone marrow cells retrovirally transduced with AML1-ETO
Organism Mus musculus
Characteristics genotype: Tet2-/-
passage number: p2
Treatment protocol To induce the CreER-mediated excision of Tet2, the cells were treated with 200 nM 4-OHT (Experimental) or EtOH (Control) for 2 passages (4 days). The cells were subsequently washed to remove residual 4-OHT and passaged every 2 days for a total of 10 to 20 passages.
Growth protocol Primary Kit-enriched bone marrow cells from Tet2fl/fl;CreER mice were freshly transduced with MigR1-AE-IRES-GFP, sorted for GFP and plated in methylcellulose medium (M3534, StemCell Technologies). After three rounds of replating, the cells were shifted to grow in suspension in non-tissue culture treated plasticware in media containing 1× StemPro®-34 SFM (Invitrogen), 1x L-Glutamine, with SCF (CHO producer cell line), 10ng/ml IL-3 (Peprotech), 10ng/ml IL-6 (Peprotech) and 0.1mM 2-mercapto-ethanol. Primary hematopoietic cell lines expressing MLL-AF9 in the Tet2fl/fl;CreER background was generated and maintained in suspension media as previously described (Somervaille, T.C.P., and Cleary, M.L. (2006), Cancer Cell 10, 257–268)
Extracted molecule total RNA
Extraction protocol Immature myeloid cells (GFP+, CD11b-, Gr1-, CD16/32+) were sorted from AML1-ETO cultures. Total RNA was isolated using the AllPrep DNA/RNA micro kit (Qiagen).
Label Biotin
Label protocol 100ng of total RNA of each sample was labeled using Ambion® WT Expression Kit (Ambion) according to manufacturers instructions
 
Hybridization protocol Affymetrix EukGE-WS2v4_450 hybridization protocol according to manufacturers instructions
Scan protocol Cell intensity files (CEL files) were generated in the GeneChip Command Console Software (AGCC) (Affymetrix, Santa Clara, CA, USA)
Description Gene expression data from Tet2-/-;AML1_ETO cells grown for 2 passages following Tet2 disruption
Data processing Raw vaules RMA-normalized and summarized using Affymetrix Power Tools (APT). Unix command: apt-probeset-summarize -a rma -a rma-bg,quant-norm.sketch=-1.bioc=true.lowprecision=false.usepm=true,pm-only,med-polish.expon=true -a pm-only,dabg.chisq=true -p ${affy_dir}/MoGene-2_0-st.pgf -c ${affy_dir}/MoGene-2_0-st.clf -b ${affy_dir}/MoGene-2_0-st.bgp --qc-probesets ${affy_dir}/MoGene-2_0-st.qcc -m ${affy_dir}/MoGene-2_0-st.mps ${cel_dir}/*.CEL -o ${out_dir}/gene_level
 
Submission date Jul 18, 2014
Last update date Apr 22, 2015
Contact name Kasper Dindler Rasmussen
E-mail(s) [email protected]
Organization name School of Life Sciences, University of Dundee
Department Division of Molecular, Cellular, and Developmental Biology (MCDB)
Street address Dow Street
City Dundee
ZIP/Postal code DD1 5EH
Country United Kingdom
 
Platform ID GPL16570
Series (2)
GSE59586 Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis (Affymetrix)
GSE59591 Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis

Data table header descriptions
ID_REF
VALUE Log2-transformed RMA normalized and summarized values

Data table
ID_REF VALUE
17200001 7.04196
17200003 7.53786
17200005 5.73886
17200007 6.35974
17200009 6.92051
17200011 6.42832
17200013 5.87756
17200015 6.40588
17200017 4.49648
17200019 5.33731
17200021 5.60312
17200023 6.98826
17200025 6.47664
17200027 6.58673
17200029 6.71995
17200031 3.30275
17200033 4.05876
17200035 4.27352
17200037 5.55778
17200039 5.05405

Total number of rows: 41345

Table truncated, full table size 684 Kbytes.




Supplementary file Size Download File type/resource
GSM1439719_KDRas-Ext-04-AML1-ETO-Kra4-MoGene-2_0-st-a1.CEL.gz 9.1 Mb (ftp)(http) CEL
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap